Windtree Therapeutics, Inc. (WINT) Misses Q2 EPS by 2091c
Tweet
Share
E-mailGet Alerts WINT Hot Sheet
Join SI Premium – FREE
Windtree Therapeutics, Inc. (NASDAQ: WINT) reported Q2 EPS of ($20.91).
For earnings history and earnings-related data on Windtree Therapeutics, Inc. (WINT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- A. O. Smith CEO Stephen Shafer named chairman
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
